Sort
64,565 grants matching “drug discovery”
Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension
$604,344Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
$604,280Timothy Palzkill · Baylor College Of Medicine · R01 · FY2021 · AI
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
$604,280Timothy Palzkill · Baylor College Of Medicine · R01 · FY2019 · AI
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
$604,280Timothy Palzkill · Baylor College Of Medicine · R01 · FY2023 · AI
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
$604,280Timothy Palzkill · Baylor College Of Medicine · R01 · FY2022 · AI
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
$604,280Timothy Palzkill · Baylor College Of Medicine · R01 · FY2020 · AI
Optimizing the immune response by targeting the Sts enzymes
$604,227Nicholas A Carpino · State University New York Stony Brook · R01 · FY2021 · AI
Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer
$604,225Katerina Abigail Politi · Yale University · R01 · FY2021 · CA
Molecular Pathways of Pain Generation in Osteoarthritis
$604,096Anne-Marie Malfait · Rush University Medical Center · R01 · FY2021 · AR
Development Of P2Y Receptor Ligands
$604,070Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Patterning myocardial specification of human pluripotent stem cells
$604,069Hee Cheol Cho · Emory University · R01 · FY2019 · HL
Spatiotemporal signaling and trafficking of the mu-opioid receptor
$604,065Ruth Huttenhain · Stanford University · R01 · FY2023 · DA
Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation
$604,063Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2025 · CA
Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation
$604,063Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2024 · CA
Systems genetics of premorbid and cocaine use traits in a rat reduced complexity cross
$604,029Camron D Bryant · Northeastern University · U01 · FY2025 · DA
Gas Chromatography-Molecular Rotational Resonance Spectrometer
$604,022Justin Lindsay Neill · Brightspec, Inc. · R44 · FY2021 · GM
Adjuvant Therapies Improving the Anti-Rejection Effects of Costimulation Blockade
$603,999Allan D. Kirk · Emory University · U01 · FY2009 · AI
Imputation-based approach to identify low frequency variants in prostate cancer
$603,954Fredrick Ray Schumacher · Case Western Reserve University · U01 · FY2016 · CA
Public HIV Drug Resistance Database
$603,954Robert W Shafer · Stanford University · R01 · FY2008 · AI
Regenbase: A Searchable Database to Organize Regeneration Knowledge via Ontologie
$603,798Vance P Lemmon · University Of Miami School Of Medicine · R01 · FY2012 · NS
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities
$603,789Bruce K Tan · Northwestern University At Chicago · R01 · FY2019 · DC
The development of a recombinant vaccine against human onchocerciasis
$603,776Sara Lustigman · New York Blood Center · R01 · FY2013 · AI
Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility
$603,769Michael J Jurynec · University Of Utah · R01 · FY2024 · AR
Macrofilaricidal Aminoacyl-tRNA Synthetase Inhibitors
$603,763Michael A. Kron · Medical College Of Wisconsin · U01 · FY2006 · AI
Characterizing the serum metabolome in multiple sclerosis
$603,729Farren B. S. Briggs · Case Western Reserve University · R01 · FY2022 · NS